SARS-Coronavirus Envelope Protein Protein (SARS-CoV E)
SARS-CoV E
Origin: SARS Coronavirus (SARS-CoV)
Host: Escherichia coli (E. coli)
Recombinant
> 95%
ELISA, WB
-
- Target See all SARS-Coronavirus Envelope Protein (SARS-CoV E) products
- SARS-Coronavirus Envelope Protein (SARS-CoV E)
- Protein Type
- Recombinant
- Origin
- SARS Coronavirus (SARS-CoV)
-
Source
- Escherichia coli (E. coli)
- Application
- ELISA, Western Blotting (WB)
- Characteristics
- Contains the E protein immunodominant region. Not full-length E protein. Contains GST fusion partner. Immunoreactive with SARS positive sera. Molecular weight is 34.7 kDa. May appear as multiple bands on SDS-PAGE (intact protein at 34.7 kDa, GST fusion protein at 26 kDa and the E fragment at 8.7 kDa).
- Purification
- GS-4B Sepharose-Affinity Purification
- Purity
- > 95%
-
-
- Application Notes
- Suitable for use in ELISA and Western Blot. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- 50 mM Tris-HCl, pH 8.0, 60 mM Sodium Chloride containing 50% Glycerol.
- Preservative
- Without preservative
- Storage
- -20 °C
- Storage Comment
- Upon receipt, store at -20°C.
-
- Target
- SARS-Coronavirus Envelope Protein (SARS-CoV E)
- Abstract
- SARS-CoV E Products
- Target Type
- Viral Protein
-
You are here:
